PRICE T ROWE ASSOCIATES INC /MD/ - TRACON PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 22 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$113,000
-38.6%
17,400
-22.3%
0.00%–
Q1 2021$184,000
+12.9%
22,400
+61.2%
0.00%–
Q4 2020$163,000–13,900–0.00%–
 Download
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 4,764,508$848,0820.28%
Ikarian Capital, LLC 2,765,530$492,2650.06%
JOHNSON & JOHNSON 84,003$14,9530.01%
BOOTHBAY FUND MANAGEMENT, LLC 258,844$46,0740.00%
BlackRock Inc. 267,821$47,6730.00%
Bank of New York Mellon Corp 10,259$1,8260.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 15,835$2,8190.00%
Truvestments Capital LLC 318$570.00%
Tower Research Capital LLC (TRC) 10,407$1,8520.00%
Cutler Group LLC / CA 1,200$00.00%
View complete list of TRACON PHARMACEUTICALS INC shareholders